Your browser doesn't support javascript.
loading
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.
Oza, Amit M; Selle, Frédéric; Davidenko, Irina; Korach, Jacob; Mendiola, Cesar; Pautier, Patricia; Chmielowska, Ewa; Bamias, Aristotelis; DeCensi, Andrea; Zvirbule, Zanete; González-Martín, Antonio; Hegg, Roberto; Joly, Florence; Zamagni, Claudio; Gadducci, Angiolo; Martin, Nicolas; Robb, Stephen; Colombo, Nicoletta.
Affiliation
  • Oza AM; *Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada; †Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, and Alliance Pour la Recherche en Cancérologie, Paris, France; ‡Chemotherapy Department of State Budgetary Healthcare Institution, Clinical Oncology Dispensary #1, Krasnodar Region Ministry of Healthcare, Krasnodar, Russia; §Gynecologic Oncology Department, Sheba Medical Center, Tel Hashomer, Israel; ∥University Hospital 12 de Octubre, Madrid, Spain; ¶Medical Departmen
Int J Gynecol Cancer ; 27(1): 50-58, 2017 01.
Article in En | MEDLINE | ID: mdl-27749456

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Glandular and Epithelial / Bevacizumab Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2017 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Glandular and Epithelial / Bevacizumab Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2017 Type: Article